Catalyst Wire Dossier Catalyst Wire Dossier

FOSCARNET SODIUM

Foscarnet sodium · Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for FOSCARNET SODIUM, covering 2021-01-29 to 2024-03-01. Get the full timeline:

Most recent: FDA Approved: FOSCARNET SODIUM — Original Application (Amneal Pharmaceuticals LLC)

See pricing